Snapdragon Chemistry Receives $1.5M DARPA Grant to Develop Continuous Technology
The US Defense Advanced Research Project Agency (DARPA) has selected Snapdragon Chemistry, Inc., for a $1.5-million grant to develop continuous technology for US-based manufacturing, a deal that will help secure the domestic supply chain and provide cost-savings for pharmaceuticals in the United States. Snapdragon is using the grant money to develop its highly automated continuous manufacturing platform to convert chemicals into valuable starting materials for pharmaceutical manufacturing. We are thrilled to be selected by DARPA to further our development efforts, said Matthew Bio, President, and CEO of Snapdragon Chemistry. This grant will allow us to bring together expertise in automation and continuous manufacturing to create a platform technology for the manufacture of pharmaceutical intermediates and fine chemicals. We expect